We noticed that several components of Ras/ERK pathway were overexpressed in fibroblastic meningioma, including SHC4, SOS2, KRAS, and CCDC6. However, c-Jun and c-Fos, two critical downstream effectors of the pathway, were detected with reduced mRNA levels in tumor tissues. The gene discussed is SHC4; the disease is neoplasm.